Mohammed Al-Omran




Dr. Mohammed Al-Omran is a Vascular Surgeon and a Scientist in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. He is a Professor at the University of Toronto in the Department of Surgery and a Full Member at the Institute of Medical Science (IMS). His research interests include: atherosclerosis bench to bedside with special interest in peripheral arterial disease; clinical epidemiology and health services research with a focus on using large healthcare administrative databases to conduct population-based analyses of individuals with aortic, carotid, and peripheral arterial disease; knowledge translation; and systematic reviews and meta-analyses.

Dr. Al-Omran has published widely in high-impact peer-reviewed journals such as the New England Journal of Medicine, Circulation and the Journal of Vascular Surgery. Dr. Al-Omran has been the recipient of several teaching and research awards, and he has supervised research trainees of all levels including: undergraduate, graduate, and post-graduate fellows. He currently serves as the Head of the Division of Vascular Surgery at St. Michael’s Hospital (2013-present) and his clinical practice is focused on management of rare vascular diseases such as thoracic outlet syndrome and carotid body tumors.

Recent Publications

  1. Leung, S, Al-Omran, M, Greco, E, Qadura, M, Wheatcroft, M, Mamdani, M et al.. Monitoring the evolving impact of COVID-19 on institutional surgical services: imperative for quality improvement platforms. Br J Surg. 2021;108 (1):e7-e8. doi: 10.1093/bjs/znaa016. PubMed PMID:33640919 PubMed Central PMC7799285.
  2. Terenzi, DC, Bakbak, E, Trac, JZ, Al-Omran, M, Quan, A, Teoh, H et al.. Isolation and characterization of circulating pro-vascular progenitor cell subsets from human whole blood samples. STAR Protoc. 2021;2 (1):100311. doi: 10.1016/j.xpro.2021.100311. PubMed PMID:33554145 PubMed Central PMC7856468.
  3. Luu, AZ, Luu, VZ, Chowdhury, B, Kosmopoulos, A, Pan, Y, Al-Omran, M et al.. Loss of endothelial cell-specific autophagy-related protein 7 exacerbates doxorubicin-induced cardiotoxicity. Biochem Biophys Rep. 2021;25 :100926. doi: 10.1016/j.bbrep.2021.100926. PubMed PMID:33553688 PubMed Central PMC7851775.
  4. Altoijry, A, Lindsay, TF, Johnston, KW, Mamdani, M, Al-Omran, M. Vascular injury-related in-hospital mortality in Ontario between 1991 and 2009. J Int Med Res. 2021;49 (1):300060520987728. doi: 10.1177/0300060520987728. PubMed PMID:33512260 PubMed Central PMC7871087.
  5. Peterson, MD, Garg, V, Mazer, CD, Chu, MWA, Bozinovski, J, Dagenais, F et al.. A randomized trial comparing axillary versus innominate artery cannulation for aortic arch surgery. J Thorac Cardiovasc Surg. 2020; :. doi: 10.1016/j.jtcvs.2020.10.152. PubMed PMID:33431219 .
  6. Hess, DA, Trac, JZ, Glazer, SA, Terenzi, DC, Quan, A, Teoh, H et al.. Vascular Risk Reduction in Obesity through Reduced Granulocyte Burden and Improved Angiogenic Monocyte Content following Bariatric Surgery. Cell Rep Med. 2020;1 (2):100018. doi: 10.1016/j.xcrm.2020.100018. PubMed PMID:33205058 PubMed Central PMC7659601.
  7. Khan, H, Gallant, RC, Zamzam, A, Jain, S, Afxentiou, S, Syed, M et al.. Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry. Diagnostics (Basel). 2020;10 (11):. doi: 10.3390/diagnostics10110871. PubMed PMID:33114560 PubMed Central PMC7693608.
  8. de Mestral, C, Hussain, MA, Austin, PC, Forbes, TL, Sivaswamy, A, Kayssi, A et al.. Regional health care services and rates of lower extremity amputation related to diabetes and peripheral artery disease: an ecological study. CMAJ Open. ;8 (4):E659-E666. doi: 10.9778/cmajo.20200048. PubMed PMID:33109531 PubMed Central PMC7595755.
  9. Rocha, RV, De Mestral, C, Tam, DY, Lee, DS, Al-Omran, M, Austin, PC et al.. Health care costs of endovascular compared with open thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2020; :. doi: 10.1016/j.jvs.2020.09.034. PubMed PMID:33098943 .
  10. Khan, H, Gallant, R, Jain, S, Al-Omran, M, De Mestral, C, Greco, E et al.. Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin. Medicina (Kaunas). 2020;56 (10):. doi: 10.3390/medicina56100519. PubMed PMID:33023261 PubMed Central PMC7600331.
Search PubMed

Affiliations & Other Activities

  • Head, Division of Vascular Surgery, St. Michael’s Hospital
  • Professor, Department of Surgery, University of Toronto
  • Associate Member, Institute of Medical Sciences, University of Toronto
  • Professor, Department of Surgery, King Saud University